Dr. Emily Miller is a Phoenix, Arizona based nurse practitioner who is specialized as Adult Health nurse. Her current practice location is 3003 N Central Ave, Suite 800, Phoenix. Patients can reach her at 602-462-1132. Dr. Emily Miller is NP with specialization in Adult Health and her NPI number (Unique professional ID assigned by NPPES) is 1396158408. Dr. Emily Miller can evaluate, diagnose patients overall wellness, and conditions such as cancer, heart disease, diabetes, arthritis, sports injuries, and other ailments. She can see patients and promote healthy living and wellness. She can perform physical examinations, order and interpret tests, prescribe medications and treatments, and can also provide education and counseling to patients on wellness strategies and disease prevention.
Complete Profile:
Dr. Emily Miller speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Emily Miller
Specialization:
Adult Health Nurse Practitioner (ANP)
Gender:
Female
Credentials:
NP
Practice Address:
3003 N Central Ave, Suite 800, Phoenix, Arizona, 85012-2902
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1396158408
NPI Enumeration Date:
05 Jun, 2014
NPI Last Update On:
24 Jul, 2015
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Emily Miller 3003 N Central Ave, Suite 800 Phoenix, Arizona
Zip:
85012-2902
Phone Number:
602-462-1132
Patients can reach Dr. Emily Miller at 3003 N Central Ave, Suite 800, Phoenix, Arizona or can call to book an appointment on 602-462-1132.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.